NPPA notified regarding the computation of the retail price of Rosuvastatin Calcium IP eq. to Rosuvastatin 20 mg (as film-coated Rosuvastatin tablet IP) + Aspirin IP 75 mg (as Aspirin Gastro-Resistant tablets IP) for M/s Pure and Cure Healthcare Pvt. Ltd. (Manufacturer) & M/s Micro Labs Ltd. (Marketer)

Feb 25, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific Complianceclass="MsoNormal" style="text-align: justify;">The National Pharmaceutical Pricing Authority (NPPA) on February 25, 2025, notified regarding the computation of the retail price of Rosuvastatin Calcium IP eq. to Rosuvastatin 20 mg (as film-coated Rosuvastatin tablet IP) + Aspirin IP 75 mg (as Aspirin Gastro-Resistant tablets IP) for M/s Pure and Cure Healthcare Pvt. Ltd. (Manufacturer) & M/s Micro Labs Ltd. (Marketer)

It states that the price of each hard gelatin capsule containing:- Rosuvastatin Calcium IP eq. to Rosuvastatin 20 mg (as film-coated Rosuvastatin tablet IP) + Aspirin IP 75 mg (as Aspirin Gastro-Resistant tablets IP) for M/s Pure and Cure Healthcare Pvt. Ltd. (Manufacturer) & M/s Micro Labs Ltd. (Marketer) has been revised to Rs. 10.73/-.

[Notification no: 19(4397)/2025/DP/NPPA/DIV.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT